Shopping Cart 0
Cart Subtotal
USD 0

Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Trovagene Inc (Trovagene) is a clinical-stage cancer therapeutics company that focuses on improved cancer care using its technology in tumor genomics. Its lead product, PCM-075, is a polo-like kinase 1 (PLK1) inhibitor that helps treat solid tumor cancers and multiple hematologic malignancies. The company's pipeline products include TROV-052 for the treatment of acute myeloid leukemia; and TROV-053 for the treatment of castration-resistant prostate cancer. Trovagene harnesses its proprietary Precision Cancer Monitoring (PCM) technology to analyze circulating tumor DNA (ctDNA) and clinically actionable markers for the detection and quantitation of oncogene mutations, which enable it to discover patients with possibility to respond to targeted cancer therapies. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc (TROV)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Trovagene Inc, Medical Equipment, Deal Details 12

Asset Purchase 12

TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12

Venture Financing 14

TrovaGene Secures USD15 Million in Venture Funding 14

Partnerships 15

Trovagene Enters Into Licensing Agreement with GenSignia IP 15

Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 16

Trovagene Enters into Agreement with Novogene 17

Trovagene Enters into Agreement for Trovera 18

Trovagene Enters into Agreement with AstraZeneca 19

Trovagene Enter into Agreements for Trovera 20

Trovagene Enters into Agreement with Boreal Genomics 21

Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 22

Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 23

Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 24

TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 25

Equity Offering 26

Trovagene Raises USD18 Million in Public Offering of Shares 26

Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants 28

Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 30

Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants 31

Trovagene Raises USD40.3 Million in Public Offering of Shares 32

Trovagene Completes Public Offering of Shares for USD23 Million 34

Trovagene Completes Private Placement Of Shares For USD 15 Million 35

Trovagene Completes Private Placement Of Units For USD 4 Million 36

Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For USD 10.6 Million 37

Trovagene Inc-Key Competitors 38

Trovagene Inc-Key Employees 39

Trovagene Inc-Locations And Subsidiaries 40

Head Office 40

Recent Developments 41

Financial Announcements 41

Aug 03, 2018: Trovagene announces second quarter 2018 highlights and financial results 41

May 08, 2018: Trovagene Announces First Quarter 2018 Highlights and Financial Results 43

Feb 26, 2018: Trovagene Announces Fourth Quarter and Full-Year 2017 Results 44

Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results 46

Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 48

May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 50

Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 52

Corporate Communications 53

Jun 22, 2018: Trovagene Announces Senior Management Change 53

Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 54

Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 55

Legal and Regulatory 57

Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 57

Product News 58

Jan 03, 2018: Trovagene to Present at the Biotech Showcase Annual Conference 58

Other Significant Developments 59

Jul 12, 2017: Trovagene Announces Agreement with Novogene for NextCollect in China 59

Jun 22, 2017: Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials 60

Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors 61

Appendix 62

Methodology 62

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Trovagene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Trovagene Inc, Medical Equipment, Key Facts, 2017 2

Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Trovagene Inc, Deals By Market, 2012 to YTD 2018 9

Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12

TrovaGene Secures USD15 Million in Venture Funding 14

Trovagene Enters Into Licensing Agreement with GenSignia IP 15

Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 16

Trovagene Enters into Agreement with Novogene 17

Trovagene Enters into Agreement for Trovera 18

Trovagene Enters into Agreement with AstraZeneca 19

Trovagene Enter into Agreements for Trovera 20

Trovagene Enters into Agreement with Boreal Genomics 21

Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 22

Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 23

Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology 24

TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 25

Trovagene Raises USD18 Million in Public Offering of Shares 26

Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants 28

Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 30

Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants 31

Trovagene Raises USD40.3 Million in Public Offering of Shares 32

Trovagene Completes Public Offering of Shares for USD23 Million 34

Trovagene Completes Private Placement Of Shares For USD 15 Million 35

Trovagene Completes Private Placement Of Units For USD 4 Million 36

Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For USD 10.6 Million 37

Trovagene Inc, Key Competitors 38

Trovagene Inc, Key Employees 39

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Trovagene Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.